Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • Xtant Medical Holdings' Depreciation & Amortization (CF) rose 820.13% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 1121.43%. This contributed to the annual value of $4.2 million for FY2024, which is 3308.13% up from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Depreciation & Amortization (CF) is $1.2 million, which was up 820.13% from $1.2 million recorded in Q2 2025.
  • Xtant Medical Holdings' Depreciation & Amortization (CF)'s 5-year high stood at $1.2 million during Q2 2025, with a 5-year trough of $281000.0 in Q1 2022.
  • In the last 5 years, Xtant Medical Holdings' Depreciation & Amortization (CF) had a median value of $803000.0 in 2023 and averaged $706631.6.
  • Per our database at Business Quant, Xtant Medical Holdings' Depreciation & Amortization (CF) plummeted by 4525.55% in 2021 and then soared by 21682.24% in 2023.
  • Xtant Medical Holdings' Depreciation & Amortization (CF) (Quarter) stood at $291000.0 in 2021, then grew by 10.31% to $321000.0 in 2022, then skyrocketed by 216.82% to $1.0 million in 2023, then increased by 12.88% to $1.1 million in 2024, then grew by 1.13% to $1.2 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.1 million in Q1 2025.